Ivan Doykov

Ivan Doykov

Population Health Sciences, University College London, London, City of London, UK
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2020 in F1000Research
Verified
Journal Article
Open access
PDF file
IDIvan Doykov
Ivan Doykov
JHJenny Hällqvist
Jenny Hällqvist
KGKimberly C. Gilmour
Kimberly C. Gilmour
LGLouis Grandjean
Louis Grandjean
KMKevin MIlls
Kevin MIlls
WHWendy E. Heywood
Wendy E. Heywood
‘Long Covid’, or medical complications associated with post SARS-CoV-2 infection, is a significant post-viral complication that is being more and more commonly reported in patients. Therefore, there is an increasing need to understand the disease mechanisms, identify drug targets and inflammatory processes associated with a SARS-CoV-2 infection. To address this need, we created a targeted mass spectrometry based multiplexed panel of 96 immune response associated proteins. We applied the multiplex assay to a cohort of serum samples from asymptomatic and moderately affected patients. All patients had tested positive for a SARS-CoV-2 infection by PCR and were determined to be subsequently positive for antibodies. Even 40-60 days post-viral infection, we observed a significant remaining inflammatory response in all patients. Proteins that were still affected were associated with the anti-inflammatory response and mitochondrial stress. This indicates that biochemical and inflammatory pathways within the body can remain perturbed long after SARS-CoV-2 infections have subsided even in asymptomatic and moderately affected patients.

20 July 2016 in Nature Communications
Verified
Journal Article
Open access
BBBlerida Banushi
Blerida Banushi
FFFederico Forneris
Federico Forneris
ASAnna Straatman-Iwanowska
Anna Straatman-Iwanowska
ASAdam Strange
Adam Strange
ALAnne-Marie Lyne
Anne-Marie Lyne
Paul GissenPaul Gissen
Paul Gissen
Post-translational modifications are necessary for collagen precursor molecules (procollagens) to acquire final shape and function. However, the mechanism and contribution of collagen modifications that occur outside the endoplasmic reticulum and Golgi are not understood. We discovered that VIPAR, with its partner proteins, regulate sorting of lysyl hydroxylase 3 (LH3, also known as PLOD3) into newly identified post-Golgi collagen IV carriers and that VIPAR-dependent sorting is essential for modification of lysines in multiple collagen types. Identification of structural and functional collagen abnormalities in cells and tissues from patients and murine models of the autosomal recessive multisystem disorder Arthrogryposis, Renal dysfunction and Cholestasis syndrome caused by VIPAR and VPS33B deficiencies confirmed our findings. Thus, regulation of post-Golgi LH3 trafficking is essential for collagen homeostasis and for the development and function of multiple organs and tissues.

8 January 2021 in F1000Research
Verified
Journal Article
Open access
PDF file
IDIvan Doykov
Ivan Doykov
JHJenny Hällqvist
Jenny Hällqvist
KGKimberly C. Gilmour
Kimberly C. Gilmour
LGLouis Grandjean
Louis Grandjean
KMKevin MIlls
Kevin MIlls
WHWendy E. Heywood
Wendy E. Heywood
‘Long Covid’, or medical complications associated with post SARS-CoV-2 infection, is a significant post-viral complication that is being more and more commonly reported in patients. Therefore, there is an increasing need to understand the disease mechanisms, identify drug targets and inflammatory processes associated with a SARS-CoV-2 infection. To address this need, we created a targeted mass spectrometry based multiplexed panel of 96 immune response associated proteins. We applied the multiplex assay to a cohort of serum samples from asymptomatic and moderately affected patients. All patients had tested positive for a SARS-CoV-2 infection by PCR and were determined to be subsequently positive for antibodies. Even 40-60 days post-viral infection, we observed a significant remaining inflammatory response in all patients. Proteins that were still affected were associated with the anti-inflammatory response and mitochondrial stress. This indicates that biochemical and inflammatory pathways within the body can remain perturbed long after SARS-CoV-2 infections have subsided even in asymptomatic and moderately affected patients.

13 September 2019 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
IDIvan Doykov
Ivan Doykov
WHWendy E Heywood
Wendy E Heywood
VNValeria Nikolaenko
Valeria Nikolaenko
JŚJustyna Śpiewak
Justyna Śpiewak
JHJenny Hällqvist
Jenny Hällqvist
KMKevin MIlls
Kevin MIlls
Background: Fabry disease is a progressive multisystemic disease, which affects the kidney and cardiovascular systems. Various treatments exist but decisions on how and when to treat are contentious. The current marker for monitoring treatment is plasma globotriaosylsphingosine (lyso-Gb3), but it is not informative about the underlying and developing disease pathology. Methods: We have created a urine proteomic assay containing a panel of biomarkers designed to measure disease-related pathology which include the inflammatory system, lysosome, heart, kidney, endothelium and cardiovascular system. Using a targeted proteomic-based approach, a series of 40 proteins for organ systems affected in Fabry disease were multiplexed into a single 10 min multiple reaction monitoring Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) assay and using only 1 mL of urine. Results: Six urinary proteins were elevated in the early-stage/asymptomatic Fabry group compared with controls including albumin, uromodulin, α1-antitrypsin, glycogen phosphorylase brain form, endothelial protein receptor C and intracellular adhesion molecule 1. Albumin demonstrated an increase in urine and could indicate presymptomatic disease. The only protein elevated in the early-stage/asymptomatic patients that continued to increase with progressive multiorgan involvement was glycogen phosphorylase brain form. Podocalyxin, fibroblast growth factor 23, cubulin and Alpha-1-Microglobulin/Bikunin Precursor (AMBP) were elevated only in disease groups involving kidney disease. Nephrin, a podocyte-specific protein, was elevated in all symptomatic groups. Prosaposin was increased in all symptomatic groups and showed greater specificity (p<0.025–0.0002) according to disease severity. Conclusion: This work indicates that protein biomarkers could be helpful and used in conjunction with plasma lyso-Gb3 for monitoring of therapy or disease progression in patients with Fabry disease.

20 November 2015 in Analytical Chemistry
Verified
Journal Article
Closed access
WHWendy E. Heywood
Wendy E. Heywood
SCStephane Camuzeaux
Stephane Camuzeaux
IDIvan Doykov
Ivan Doykov
NPNina Patel
Nina Patel
RPRhian-Lauren Preece
Rhian-Lauren Preece
KMKevin MIlls
Kevin MIlls

1 October 2019 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
WHWendy E. Heywood
Wendy E. Heywood
IDIvan Doykov
Ivan Doykov
JSJustyna Spiewak
Justyna Spiewak
JHJenny Hallqvist
Jenny Hallqvist
KMKevin Mills
Kevin Mills
ANAlbina Nowak
Albina Nowak